pentoxifylline has been researched along with Parodontosis in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Concomitantly to AIA, mice presented alveolar bone loss, and recruitment of osteoclasts and neutrophils to periodontal tissues." | 1.39 | Preventive and therapeutic anti-TNF-α therapy with pentoxifylline decreases arthritis and the associated periodontal co-morbidity in mice. ( Bessoni, RL; Costa, VV; Queiroz-Junior, CM; Silva, TA; Souza, DG; Teixeira, MM, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Queiroz-Junior, CM | 1 |
| Bessoni, RL | 1 |
| Costa, VV | 1 |
| Souza, DG | 1 |
| Teixeira, MM | 1 |
| Silva, TA | 1 |
1 other study available for pentoxifylline and Parodontosis
| Article | Year |
|---|---|
Preventive and therapeutic anti-TNF-α therapy with pentoxifylline decreases arthritis and the associated periodontal co-morbidity in mice.
Topics: Alveolar Bone Loss; Animals; Antigens; Arthritis, Experimental; Arthritis, Rheumatoid; C-Reactive Pr | 2013 |